Growth Metrics

Axogen (AXGN) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Axogen (AXGN) over the last 16 years, with Q3 2025 value amounting to $216.4 million.

  • Axogen's Liabilities and Shareholders Equity rose 1271.71% to $216.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $821.7 million, marking a year-over-year increase of 752.18%. This contributed to the annual value of $203.7 million for FY2024, which is 350.61% up from last year.
  • Per Axogen's latest filing, its Liabilities and Shareholders Equity stood at $216.4 million for Q3 2025, which was up 1271.71% from $205.5 million recorded in Q2 2025.
  • Axogen's Liabilities and Shareholders Equity's 5-year high stood at $216.4 million during Q3 2025, with a 5-year trough of $186.5 million in Q1 2024.
  • Its 5-year average for Liabilities and Shareholders Equity is $198.6 million, with a median of $196.2 million in 2025.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first surged by 3622.65% in 2021, then crashed by 688.24% in 2022.
  • Quarter analysis of 5 years shows Axogen's Liabilities and Shareholders Equity stood at $208.0 million in 2021, then fell by 6.07% to $195.4 million in 2022, then grew by 0.74% to $196.8 million in 2023, then grew by 3.51% to $203.7 million in 2024, then grew by 6.22% to $216.4 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $216.4 million for Q3 2025, versus $205.5 million for Q2 2025 and $196.2 million for Q1 2025.